CompletedPhase 2NCT00407485

VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium

Studying Twin-reversed arterial perfusion sequence

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Institute (NCI)
Principal Investigator
Przemyslaw Twardowski
City of Hope Medical Center
Intervention
ziv-aflibercept(biological)
Enrollment
22 enrolled
Eligibility
18 years · All sexes
Timeline
20062014

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00407485 on ClinicalTrials.gov

Other trials for Twin-reversed arterial perfusion sequence

Additional recruiting or active studies for the same condition.

See all trials for Twin-reversed arterial perfusion sequence

← Back to all trials